Skip to content

The Glycemic Effect of Taking a Supplementation of Orange Juice With Fibers

Status
UNKNOWN
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00966862
Enrollment
Unknown
Registered
2009-08-27
Start date
2009-09-30
Completion date
2010-05-31
Last updated
2009-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy People

Brief summary

The aim of this study is to investigate the glycemic effect of supplementation Fibers in orange juice. This will be a double-blind parallel controlled study. Each subject will serve as his own control. Study population will include 10 subjects. The subjects will be randomly assigned to receive one of two juices in occasion, in two visits. Each drink will be containing orange juice with\\without fibers.

Interventions

OTHEROther: Dietary Fibers

Sponsors

Tel-Aviv Sourasky Medical Center
Lead SponsorOTHER_GOV

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy Volunteers * Age 60 \>18 years * Written informed consent * Consumers of orange drinks: freshly squeezed juices, commercial pasteurized juices and / or orange soft drinks * Regular eating pattern

Exclusion criteria

* Patients with chronic disease sach as: * diabetes, * cancer, * C.O.P.D., * metabolic syndrome, * overweight, * kidney failure, * heart disease, * osteoporosis. * Antibiotic treatment in the last 4 weeks * Subjects on regular probiotic or prebiotic supplementation, unless they do 2 weeks of wash out. * Subjects with intestinal disorders such as: IBD, IBS, celiac, colon cancer. * Subjects after intestinal surgery. * Use of medicines for lowering cholesterol (simvastatin), sugar control * Pregnancy

Design outcomes

Primary

MeasureTime frame
To investigate the Glycemic Effect by drawing blood for glucose and insulin

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026